DNA replication stress and cancer chemotherapy

Hiroyuki Kitao, Makoto Iimori, Yuki Kataoka, Takeshi Wakasa, Eriko Tokunaga, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

DNA replication is one of the fundamental biological processes in which dysregulation can cause genome instability. This instability is one of the hallmarks of cancer and confers genetic diversity during tumorigenesis. Numerous experimental and clinical studies have indicated that most tumors have experienced and overcome the stresses caused by the perturbation of DNA replication, which is also referred to as DNA replication stress (DRS). When we consider therapeutic approaches for tumors, it is important to exploit the differences in DRS between tumor and normal cells. In this review, we introduce the current understanding of DRS in tumors and discuss the underlying mechanism of cancer therapy from the aspect of DRS.

Original languageEnglish
Pages (from-to)264-271
Number of pages8
JournalCancer Science
Volume109
Issue number2
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

DNA Replication
Drug Therapy
Neoplasms
Biological Phenomena
Genomic Instability
Carcinogenesis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., ... Maehara, Y. (2018). DNA replication stress and cancer chemotherapy. Cancer Science, 109(2), 264-271. https://doi.org/10.1111/cas.13455

DNA replication stress and cancer chemotherapy. / Kitao, Hiroyuki; Iimori, Makoto; Kataoka, Yuki; Wakasa, Takeshi; Tokunaga, Eriko; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko.

In: Cancer Science, Vol. 109, No. 2, 01.02.2018, p. 264-271.

Research output: Contribution to journalReview article

Kitao, H, Iimori, M, Kataoka, Y, Wakasa, T, Tokunaga, E, Saeki, H, Oki, E & Maehara, Y 2018, 'DNA replication stress and cancer chemotherapy', Cancer Science, vol. 109, no. 2, pp. 264-271. https://doi.org/10.1111/cas.13455
Kitao H, Iimori M, Kataoka Y, Wakasa T, Tokunaga E, Saeki H et al. DNA replication stress and cancer chemotherapy. Cancer Science. 2018 Feb 1;109(2):264-271. https://doi.org/10.1111/cas.13455
Kitao, Hiroyuki ; Iimori, Makoto ; Kataoka, Yuki ; Wakasa, Takeshi ; Tokunaga, Eriko ; Saeki, Hiroshi ; Oki, Eiji ; Maehara, Yoshihiko. / DNA replication stress and cancer chemotherapy. In: Cancer Science. 2018 ; Vol. 109, No. 2. pp. 264-271.
@article{5700a893960c4e73a19d41420d492df3,
title = "DNA replication stress and cancer chemotherapy",
abstract = "DNA replication is one of the fundamental biological processes in which dysregulation can cause genome instability. This instability is one of the hallmarks of cancer and confers genetic diversity during tumorigenesis. Numerous experimental and clinical studies have indicated that most tumors have experienced and overcome the stresses caused by the perturbation of DNA replication, which is also referred to as DNA replication stress (DRS). When we consider therapeutic approaches for tumors, it is important to exploit the differences in DRS between tumor and normal cells. In this review, we introduce the current understanding of DRS in tumors and discuss the underlying mechanism of cancer therapy from the aspect of DRS.",
author = "Hiroyuki Kitao and Makoto Iimori and Yuki Kataoka and Takeshi Wakasa and Eriko Tokunaga and Hiroshi Saeki and Eiji Oki and Yoshihiko Maehara",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/cas.13455",
language = "English",
volume = "109",
pages = "264--271",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - DNA replication stress and cancer chemotherapy

AU - Kitao, Hiroyuki

AU - Iimori, Makoto

AU - Kataoka, Yuki

AU - Wakasa, Takeshi

AU - Tokunaga, Eriko

AU - Saeki, Hiroshi

AU - Oki, Eiji

AU - Maehara, Yoshihiko

PY - 2018/2/1

Y1 - 2018/2/1

N2 - DNA replication is one of the fundamental biological processes in which dysregulation can cause genome instability. This instability is one of the hallmarks of cancer and confers genetic diversity during tumorigenesis. Numerous experimental and clinical studies have indicated that most tumors have experienced and overcome the stresses caused by the perturbation of DNA replication, which is also referred to as DNA replication stress (DRS). When we consider therapeutic approaches for tumors, it is important to exploit the differences in DRS between tumor and normal cells. In this review, we introduce the current understanding of DRS in tumors and discuss the underlying mechanism of cancer therapy from the aspect of DRS.

AB - DNA replication is one of the fundamental biological processes in which dysregulation can cause genome instability. This instability is one of the hallmarks of cancer and confers genetic diversity during tumorigenesis. Numerous experimental and clinical studies have indicated that most tumors have experienced and overcome the stresses caused by the perturbation of DNA replication, which is also referred to as DNA replication stress (DRS). When we consider therapeutic approaches for tumors, it is important to exploit the differences in DRS between tumor and normal cells. In this review, we introduce the current understanding of DRS in tumors and discuss the underlying mechanism of cancer therapy from the aspect of DRS.

UR - http://www.scopus.com/inward/record.url?scp=85038847947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038847947&partnerID=8YFLogxK

U2 - 10.1111/cas.13455

DO - 10.1111/cas.13455

M3 - Review article

C2 - 29168596

AN - SCOPUS:85038847947

VL - 109

SP - 264

EP - 271

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 2

ER -